1,700,142 Shares in Definitive Healthcare Corp. (NASDAQ:DH) Acquired by Millennium Management LLC

Millennium Management LLC purchased a new stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 1,700,142 shares of the company’s stock, valued at approximately $9,283,000. Millennium Management LLC owned approximately 1.44% of Definitive Healthcare as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Norden Group LLC bought a new stake in Definitive Healthcare during the first quarter worth approximately $83,000. Canada Pension Plan Investment Board bought a new stake in shares of Definitive Healthcare during the 2nd quarter worth $109,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after buying an additional 5,083 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in Definitive Healthcare in the 1st quarter worth about $120,000. Finally, Hennion & Walsh Asset Management Inc. acquired a new stake in Definitive Healthcare during the 2nd quarter worth about $127,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH opened at $4.21 on Wednesday. The company has a market cap of $496.51 million, a price-to-earnings ratio of -2.41, a PEG ratio of 6.49 and a beta of 1.33. The business has a 50 day moving average price of $4.26 and a 200 day moving average price of $5.52. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare Corp. has a twelve month low of $3.19 and a twelve month high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The business had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The firm’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the company earned $0.08 earnings per share. Research analysts predict that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DH. Robert W. Baird dropped their target price on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Tuesday, August 6th. Barclays decreased their target price on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. BTIG Research began coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. Finally, Stifel Nicolaus lowered their target price on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.